Associate Professor, Molecular Medicine, Scripps Research Institute
BIOGRAPHY
Speaker
Event Date & Time
DATE: November 7, 2019
TIME: 9:00am PST, 12:00pm EST
Abstract
In collaboration with Hematherix and Thermo Fisher, Dr. Laurent Mosnier is investigating a new treatment for acute traumatic bleeding using an engineered Factor V molecule. Acute traumatic bleeding is a major clinical issue without suitable prohemostatic treatment options. Most available prohemostatic drugs carry a high risk of thrombosis in acute traumatic bleeding. This webinar proposes a targeted therapy for acute traumatic bleeding using engineered Factor V molecules.
Learning Objectives:
- Identify techniques to optimize expression levels of recombinant proteins
- Demonstrate how to improve yields of recombinant proteins using ExpiCHO
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...